Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$75.00
Provider: Reuters Investment Profile
$20.00
Provider: Equity Development
$100.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Immunodiagnostic Systems Holdings PLC announces FDA clearance for direct renin assay


Thursday, 9 Jan 2014 02:00am EST 

Immunodiagnostic Systems Holdings PLC:Says has received USA FDA (Food and Drug Administration) clearance for its Direct Renin assay for use on its IDS-iSYS system, enabling IDS to enter the US market with this product.Says IDS-iSYS Direct Renin immunoassay is used to determine the amount of active renin present in the blood. 

Company Quote

297.5
0.0 +0.00%
31 Oct 2014